These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36556972)

  • 1. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
    Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
    Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
    BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
    Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
    Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
    BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
    Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
    BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
    Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
    Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
    Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
    Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
    Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Clapper ML; Chang WL; Cooper HS
    Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
    Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
    Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
    Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
    Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
    Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
    J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in subjects with hereditary nonpolyposic and sporadic colon rectal cancer.
    Ramírez-Ramírez MA; Sobrino-Cossío S; de la Mora-Levy JG; Hernández-Guerrero A; Macedo-Reyes Vde J; Maldonado-Martínez HA; Alonso-Larraga JO; Ramírez-Solis ME
    J Gastrointest Cancer; 2012 Jun; 43(2):209-14. PubMed ID: 21744313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of human rectal aberrant crypt foci and formation of colorectal polyp: One-year following up after polypectomy.
    Takahashi H; Yamada E; Ohkubo H; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Nakajima A
    World J Gastrointest Endosc; 2012 Dec; 4(12):561-4. PubMed ID: 23293726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.